(MDB) MongoDB - Ratings and Ratios
Database Platform, Atlas Cloud, Enterprise Advanced, Community Server
Dividends
Currently no dividends paid| Risk via 10d forecast | |
|---|---|
| Volatility | 56.3% |
| Value at Risk 5%th | 75.9% |
| Relative Tail Risk | -18.11% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.54 |
| Alpha | 4.85 |
| CAGR/Max DD | 0.41 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.508 |
| Beta | 1.620 |
| Beta Downside | 1.570 |
| Drawdowns 3y | |
|---|---|
| Max DD | 70.88% |
| Mean DD | 30.75% |
| Median DD | 30.59% |
Description: MDB MongoDB October 14, 2025
MongoDB, Inc. (NASDAQ: MDB) delivers a general-purpose, document-oriented database platform that powers modern applications across cloud, on-premises, and hybrid environments. Its commercial offerings include MongoDB Atlas-a fully managed, multi-cloud Database-as-a-Service (DBaaS)-and MongoDB Enterprise Advanced, while the free Community Server serves as an entry point for developers.
Beyond software, the company monetizes professional services such as consulting and training, and it has evolved from its original 10gen branding (renamed in 2013) to a publicly traded entity headquartered in New York.
Key recent metrics (FY 2024): revenue of approximately $1.5 billion, representing ~20 % year-over-year growth; subscription-based annual recurring revenue (ARR) expanding at ~40 % CAGR, driven largely by Atlas adoption; and a gross margin of roughly 73 %, reflecting the high-margin nature of its SaaS model.
Sector drivers that underpin MongoDB’s outlook include the accelerating shift of enterprises toward multi-cloud strategies, the rising demand for flexible, schema-less data stores to support real-time analytics, and the broader growth of the cloud infrastructure market, which is projected to expand at ~15 % annually through 2028.
For a deeper, data-driven valuation framework, you might explore ValueRay’s detailed model on MongoDB.
Piotroski VR‑10 (Strict, 0-10) 3.0
| Net Income (-70.9m TTM) > 0 and > 6% of Revenue (6% = 139.0m TTM) |
| FCFTA 0.10 (>2.0%) and ΔFCFTA 5.35pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 102.5% (prev 60.20%; Δ 42.27pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.11 (>3.0%) and CFO 384.4m > Net Income -70.9m (YES >=105%, WARN >=100%) |
| NO Net Debt/EBITDA fails (EBITDA <= 0) |
| Current Ratio 5.25 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (81.2m) change vs 12m ago 9.76% (target <= -2.0% for YES) |
| Gross Margin 71.62% (prev 73.72%; Δ -2.10pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 68.24% (prev 59.42%; Δ 8.82pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio -9.95 (EBITDA TTM -32.5m / Interest Expense TTM 6.71m) >= 6 (WARN >= 3) |
Altman Z'' -0.49
| (A) 0.67 = (Total Current Assets 2.93b - Total Current Liabilities 558.0m) / Total Assets 3.57b |
| (B) -0.54 = Retained Earnings (Balance) -1.93b / Total Assets 3.57b |
| (C) -0.02 = EBIT TTM -66.8m / Avg Total Assets 3.40b |
| (D) -2.83 = Book Value of Equity -1.92b / Total Liabilities 678.2m |
| Total Rating: -0.49 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 51.20
| 1. Piotroski 3.0pt |
| 2. FCF Yield 1.18% |
| 3. FCF Margin 15.30% |
| 4. Debt/Equity 0.01 |
| 5. Debt/Ebitda 24.58 |
| 6. ROIC - WACC (= -21.48)% |
| 7. RoE -2.43% |
| 8. Rev. Trend 98.72% |
| 9. EPS Trend 85.68% |
What is the price of MDB shares?
Over the past week, the price has changed by +23.24%, over one month by +16.94%, over three months by +26.14% and over the past year by +22.53%.
Is MDB a buy, sell or hold?
- Strong Buy: 19
- Buy: 9
- Hold: 12
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the MDB price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 430.2 | 5% |
| Analysts Target Price | 430.2 | 5% |
| ValueRay Target Price | 421.4 | 2.9% |
MDB Fundamental Data Overview December 06, 2025
P/E Forward = 71.9424
P/S = 13.9356
P/B = 11.4388
P/EG = 1.6716
Beta = 1.454
Revenue TTM = 2.32b USD
EBIT TTM = -66.8m USD
EBITDA TTM = -32.5m USD
Long Term Debt = 34.6m USD (from capitalLeaseObligations, last quarter)
Short Term Debt = 9.14m USD (from shortTermDebt, last quarter)
Debt = 34.6m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -799.5m USD (from netDebt column, last quarter)
Enterprise Value = 30.02b USD (32.29b + Debt 34.6m - CCE 2.31b)
Interest Coverage Ratio = -9.95 (Ebit TTM -66.8m / Interest Expense TTM 6.71m)
FCF Yield = 1.18% (FCF TTM 354.6m / Enterprise Value 30.02b)
FCF Margin = 15.30% (FCF TTM 354.6m / Revenue TTM 2.32b)
Net Margin = -3.06% (Net Income TTM -70.9m / Revenue TTM 2.32b)
Gross Margin = 71.62% ((Revenue TTM 2.32b - Cost of Revenue TTM 657.7m) / Revenue TTM)
Gross Margin QoQ = 71.48% (prev 71.01%)
Tobins Q-Ratio = 8.42 (Enterprise Value 30.02b / Total Assets 3.57b)
Interest Expense / Debt = 7.33% (Interest Expense 2.54m / Debt 34.6m)
Taxrate = 248.7% (out of range, set to none) (3.36m / 1.35m)
NOPAT = unknown (EBIT/Op.Income or Taxrate missing)
Current Ratio = 5.25 (Total Current Assets 2.93b / Total Current Liabilities 558.0m)
Debt / Equity = 0.01 (Debt 34.6m / totalStockholderEquity, last quarter 2.89b)
Debt / EBITDA = 24.58 (negative EBITDA) (Net Debt -799.5m / EBITDA -32.5m)
Debt / FCF = -2.25 (Net Debt -799.5m / FCF TTM 354.6m)
Total Stockholder Equity = 2.91b (last 4 quarters mean from totalStockholderEquity)
RoA = -1.99% (Net Income -70.9m / Total Assets 3.57b)
RoE = -2.43% (Net Income TTM -70.9m / Total Stockholder Equity 2.91b)
RoCE = -2.27% (EBIT -66.8m / Capital Employed (Equity 2.91b + L.T.Debt 34.6m))
RoIC = -9.50% (negative operating profit) (EBIT -66.8m / (Assets 3.57b - Curr.Liab 558.0m - Cash 2.31b))
WACC = 11.98% (E(32.29b)/V(32.33b) * Re(11.99%) + (debt cost/tax rate unavailable))
Discount Rate = 11.99% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 6.55%
[DCF Debug] Terminal Value 69.68% ; FCFE base≈271.9m ; Y1≈335.5m ; Y5≈572.4m
Fair Price DCF = 65.64 (DCF Value 5.34b / Shares Outstanding 81.4m; 5y FCF grow 25.0% → 3.0% )
EPS Correlation: 85.68 | EPS CAGR: 70.94% | SUE: 3.58 | # QB: 13
Revenue Correlation: 98.72 | Revenue CAGR: 25.70% | SUE: 3.78 | # QB: 17
EPS next Quarter (2026-04-30): EPS=1.19 | Chg30d=+0.223 | Revisions Net=+5 | Analysts=29
EPS next Year (2027-01-31): EPS=5.49 | Chg30d=+1.139 | Revisions Net=+9 | Growth EPS=+14.0% | Growth Revenue=+18.0%
Additional Sources for MDB Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle